Maria Helene Edebrink

Senior Executive

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Sep 24, 2020 – Sep 5, 2023

Maria Helene Edebrink reported 18 transactions between Sep 24, 2020 and Sep 5, 2023. The buy and sell totals below count only codes SACQ, SDIS.

Open-market buys (SACQ)
681.4K SEK
8 purchases on file priced rows only
Open-market sales (SDIS)
299.6K SEK
2 sales on file priced rows only
All reported transactions
18
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought Xbrane Biopharma AB shares worth 652,968 SEK between Jun 1, 2022 and Jun 20, 2022

Cluster buying

3 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Xbrane Biopharma AB shares worth 652,968 SEK between Jun 1, 2022 and Jun 20, 2022
Date Insider Transaction Shares Price Value Filing
Jun 1, 2022 Nina Ivers SACQ Acquisition 1,500 67.50 SEK 101,250 SEK FI filing ↗
Jun 1, 2022 Karl Martin Erik Åmark SACQ Acquisition 2,500 64.70 SEK 161,750 SEK FI filing ↗
Jun 10, 2022 Maria Helene Edebrink SACQ Acquisition 1,500 69.00 SEK 103,500 SEK FI filing ↗
Jun 16, 2022 Maria Helene Edebrink SACQ Acquisition 1,095 69.70 SEK 76,322 SEK FI filing ↗
Jun 20, 2022 Maria Helene Edebrink SACQ Acquisition 3,185 65.98 SEK 210,146 SEK FI filing ↗

Total of the rows above: 652,968 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 18 most recent rows are grouped into 15 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Xbrane Biopharma AB SEXI Exercise increase × 2not a buy/sell decision 7,300 shares 1.6K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    4,300 0.22 SEK 964 SEK FI filing ↗
    3,000 0.22 SEK 673 SEK FI filing ↗
  2. Xbrane Biopharma AB SEXD Exercise decrease × 2not a buy/sell decisionreported at zero 7,300 shares 0 SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    4,300 0.00 SEKreported at zero 0 SEK FI filing ↗
    3,000 0.00 SEKreported at zero 0 SEK FI filing ↗
  3. Xbrane Biopharma AB SALL Allotment × 2not a buy/sell decisionreported at zero 7,300 shares 0 SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    4,300 0.00 SEKreported at zero 0 SEK FI filing ↗
    3,000 0.00 SEKreported at zero 0 SEK FI filing ↗
  4. Xbrane Biopharma AB SACQ Acquisition 3,185 shares 210.1K SEK at 65.98 SEK FI filing ↗
  5. Xbrane Biopharma AB SDIS Disposal 3,185 shares 223.0K SEK at 70.00 SEK FI filing ↗
  6. Xbrane Biopharma AB SACQ Acquisition 1,095 shares 76.3K SEK at 69.70 SEK FI filing ↗
  7. Xbrane Biopharma AB SDIS Disposal 1,095 shares 76.7K SEK at 70.00 SEK FI filing ↗
  8. Xbrane Biopharma AB SACQ Acquisition 1,500 shares 103.5K SEK at 69.00 SEK FI filing ↗
  9. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 1,690 shares 116.3K SEK at 68.80 SEK FI filing ↗
  10. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 650 shares 108.9K SEK at 167.60 SEK FI filing ↗
  11. Xbrane Biopharma AB SACQ Acquisition 1,000 shares 117.8K SEK at 117.80 SEK FI filing ↗
  12. Xbrane Biopharma AB SACQ Acquisition 750 shares 57.2K SEK at 76.20 SEK FI filing ↗
  13. Xbrane Biopharma AB SACQ Acquisition 200 shares 17.0K SEK at 85.00 SEK FI filing ↗
  14. Xbrane Biopharma AB SACQ Acquisition 750 shares 61.2K SEK at 81.60 SEK FI filing ↗
  15. Xbrane Biopharma AB SACQ Acquisition 450 shares 38.3K SEK at 85.00 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Xbrane Biopharma AB SE0007789409 Xbrane Biopharma AB 14,290 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Maria Helene Edebrink reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.